Liz Parrish
Founder and CEO of BioViva
Liz Parrish is the founder and CEO of BioViva, a company that promotes gene therapies aimed at aging. In 2015 she said she had received experimental telomerase and follistatin gene therapies outside the United States, without regulatory approval, and she has continued to experiment on herself since. She calls herself patient zero for her company's approach.
Updated November 1, 2026 · 2 experiments
What Liz Parrish has tried
2 experiments we can source: 2 testing. Trying something is not recommending it; each entry says which.
Testing
Follistatin gene therapyTherapies
Started Sep 2015 · Does not recommend it to others
Had injections of the follistatin gene into her muscles in 2015, alongside a telomerase gene therapy, as an unapproved self-experiment aimed at age-related muscle loss.
“We are attempting to reverse aging at a biological level.”
MIT Technology Review, A Tale of Do-It-Yourself Gene Therapy (October 2015) · Status checked October 14, 2015 · Suggest a correction
Telomerase gene therapyTherapies
Started Sep 2015 · Does not recommend it to others
Had an unapproved telomerase gene therapy abroad in 2015, hoping to lengthen her telomeres, and has continued experimenting on herself since.
“the most genetically modified person on Earth.”
MIT Technology Review, Why reprogramming is the buzziest approach to reversing aging right now (June 2026) · Status checked June 12, 2026 · Suggest a correction